-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Sangamo Therapeutics, Inc quarterly/annual Depreciation, Depletion and Amortization history and growth rate from 2010 to 2023.
- Sangamo Therapeutics, Inc Depreciation, Depletion and Amortization for the quarter ending March 31, 2024 was $1.41M, a 59.7% decline year-over-year.
- Sangamo Therapeutics, Inc annual Depreciation, Depletion and Amortization for 2023 was $15.1M, a 24.4% increase from 2022.
- Sangamo Therapeutics, Inc annual Depreciation, Depletion and Amortization for 2022 was $12.1M, a 28.3% increase from 2021.
- Sangamo Therapeutics, Inc annual Depreciation, Depletion and Amortization for 2021 was $9.44M, a 66.1% increase from 2020.
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Growth (%)